- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin, cancer and glucose metabolism
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 21, Issue 6, Pages R461-R471
Publisher
Bioscientifica
Online
2014-10-02
DOI
10.1530/erc-14-0284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle
- (2014) Jonas Møller Kristensen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Diabetes and cancer: 5years into the recent controversy
- (2014) Ellena Badrick et al. EUROPEAN JOURNAL OF CANCER
- Type 2 diabetes as a redox disease
- (2014) James D Watson LANCET
- Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
- (2014) Kıvanç Birsoy et al. NATURE
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transport of biguanides by human organic cation transporter OCT2
- (2013) Yoshihisa Sogame et al. BIOMEDICINE & PHARMACOTHERAPY
- A common novel splice variant ofSLC22A1(OCT1)is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia
- (2013) Jacob Grinfeld et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
- (2013) Krushna C. Patra et al. CANCER CELL
- Association of metformin use with cancer incidence and mortality: A meta-analysis
- (2013) Pengpeng Zhang et al. Cancer Epidemiology
- Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models
- (2013) P. Zhu et al. Cancer Prevention Research
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
- (2013) Cecilia Marini et al. CELL CYCLE
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Metformin Temporal and Localized Effects on Gut Glucose Metabolism Assessed Using 18F-FDG PET in Mice
- (2013) M. Massollo et al. JOURNAL OF NUCLEAR MEDICINE
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
- (2013) Shanmiao Gou et al. PLoS One
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
- (2012) R. J. Stevens et al. DIABETOLOGIA
- Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
- (2012) Dara Hope Cohen et al. ENDOCRINE-RELATED CANCER
- MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene
- (2012) Rong Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparative Analysis of Pharmacophore Screening Tools
- (2012) Marijn P. A. Sanders et al. Journal of Chemical Information and Modeling
- Metformin: A Diabetes Drug for Cancer, or a Cancer Drug for Diabetics?
- (2012) Matthew Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
- (2012) Weiwei Yang et al. NATURE CELL BIOLOGY
- Relevance of the OCT1 transporter to the antineoplastic effect of biguanides
- (2011) Eric D. Segal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells
- (2011) Barbara Salani et al. FASEB JOURNAL
- Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking
- (2011) Fabiana Caporuscio et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse
- (2010) Daniel Da Silva et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- Drug Transporters and Imatinib Treatment: Implications for Clinical Practice
- (2010) K. Eechoute et al. CLINICAL CANCER RESEARCH
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Energy restriction as an antitumor target
- (2010) Hany A Omar et al. Future Oncology
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes
- (2010) Alberto Del Rio et al. Molecular BioSystems
- Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice
- (2010) Shuanglian Li et al. PHARMACEUTICAL RESEARCH
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin
- (2010) Ligong Chen et al. Pharmacogenetics and Genomics
- AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC
- (2009) M. P. Sajan et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
- (2009) Anne T. Nies et al. HEPATOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
- (2008) G. Caleb Alexander et al. ARCHIVES OF INTERNAL MEDICINE
- Organic Cation Transporters and their Pharmacokinetic and Pharmacodynamic Consequences
- (2008) Min-Koo Choi et al. Drug Metabolism and Pharmacokinetics
- Polymorphism in human organic cation transporters and metformin action
- (2008) Hiroshi Takane et al. PHARMACOGENOMICS
- The role of insulin receptors and IGF-I receptors in cancer and other diseases
- (2008) Francesco Frasca et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Metformin and glitazones: does similarity in biomolecular mechanism originate from tautomerism in these drugs?
- (2007) Sandeep Sundriyal et al. JOURNAL OF PHYSICAL ORGANIC CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation